TELA Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TELA Bio, Inc. on May 30, 2025, covering events occurring on that date with an effective date of June 2, 2025. The filing details significant changes to the Company's Board of Directors and executive leadership structure.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes
- Board Resignation: Jeffrey Blizard resigned from the Board of Directors and the Nominating and Corporate Governance Committee, effective June 2, 2025. The resignation was not due to any disagreement with the Company.
- Executive Appointment: Jeffrey Blizard was appointed as the new President of the Company, effective June 2, 2025.
- Role Transition: Antony Koblish will continue as Chief Executive Officer but will no longer hold the title of President as of the effective date.
Compensation, Outlook, and Risks
The filing outlines a new employment agreement for Mr. Blizard effective June 2, 2025, with the following terms:
- Base Salary: $475,000 annually.
- Bonus: Target annual bonus of 50% of base salary (pro-rated for 2025).
- Sign-on Bonus: $150,000 cash.
- Equity Awards:
- Option to purchase 154,100 shares (vesting 25% at one year, remainder over 36 months).
- 104,800 Restricted Stock Units (vesting in four equal annual installments).
- Severance:
- Termination without Cause/Good Reason: 9 months' salary plus accrued bonuses and benefits.
- Change of Control Termination: 12 months' salary, pro-rated bonus, and acceleration of service-based equity vesting.
The Company issued a press release on June 2, 2025, regarding this appointment. No specific risks or contingencies beyond standard employment terms were disclosed in this filing.
Investor Verification Checklist
- Verify the full text of the Blizard Employment Agreement in the upcoming Form 10-Q for the quarter ended June 30, 2025.
- Confirm the impact of the leadership transition on the Company's strategic direction via the June 2, 2025 press release.
- Monitor future filings for any changes to the Board composition following Mr. Blizard's resignation.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.